A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... Alzheimer's Treatment One Step ...

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

Regularly eating red meat has been linked with heart disease, diabetes and several types of cancer. Now there’s fresh ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

Dr. Bayram says, overall, this study provides a promising step in advancing dementia prevention and care. "We are seeing more and more treatment trials that are focused on disease modification for ...